Despite the presence of many hematological prognostic indexes, clinical course and overall
survival are often highly variable even within the same patient subgroup. Recent studies …

(1) Background: Since its discovery, COVID-19 has caused more than 256 million cases,
with a cumulative death toll of more than 5.1 million, worldwide. Early identification of …

Abstract Purpose of Review Estimating and modifying thrombotic risk is currently the
mainstay of care for patients with polycythemia vera (PV) and essential thrombocythemia …

The impact of inflammatory markers such as systemic immune-inflammation (SII) index and
systemic inflammation response index (SIRI) on myelofibrosis (MF) prognosis was evaluated …

Objective To explore the possibility of obtaining more accurate information from routine
blood tests for the diagnosis of periprosthetic joint infection (PJI). Methods This is a …

(1) Background: This study aims to evaluate the association of CRP, NLR, IL-6, and
Procalcitonin with lung damage observed on CT scans;(2) Methods: A cross-sectional study …

Sažetak Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR)
emerged as rapidly available biomarkers of inflammation and advanced atherosclerosis …

Discriminating polycythemia vera (PV) from secondary polycythemia (SP) is crucial due to
the inherent risk of thrombosis in PV and different treatment approaches. The majority of PV …

Cardiovascular (CV) risk factors are important contributors to thrombotic risk in the general
population and in patients with chronic myeloproliferative neoplasms (MPNs). However, the …

Background: Osteoarthritis (OA) is a progressive degenerative disease with an inflammatory
background. Chronic myeloproliferative neoplasms (MPN) are clonal hematopoietic …